Related Experiment Videos
Interaction between alpha 1 antitrypsin and lymphocyte surface proteases: immunoregulatory effects
Agents and Actions
|December 1, 1981
Summary
Alpha 1 antitrypsin (alpha 1-AT), a key plasma protease inhibitor, binds to lymphocytes via a surface protease receptor. This interaction inhibits lymphocyte activity, suggesting alpha 1-AT mediates monocyte-lymphocyte communication.
Area of Science:
- Immunology
- Biochemistry
- Cell Biology
Background:
- Alpha 1 antitrypsin (alpha 1-AT) is the primary protease inhibitor found in plasma.
- Understanding its interactions with immune cells is crucial for immunology research.
Purpose of the Study:
- To investigate the binding characteristics of alpha 1-AT to human lymphocytes.
- To determine the functional consequences of alpha 1-AT binding on lymphocyte activity.
- To explore the role of alpha 1-AT in cell-cell interactions.
Main Methods:
- Radioiodination of alpha 1-AT for binding assays.
- Lymphocyte stimulation assays using mitogens and allogeneic cells.
- Measurement of 3H-thymidine incorporation to assess lymphocyte proliferation.
- Identification of alpha 1-AT receptor as a surface-associated protease.
Main Results:
- Radioiodinated alpha 1-AT demonstrated fast, reversible binding to human lymphocytes, with saturation at approximately 1.2 x 10^6 molecules per cell.
- A surface-associated protease was identified as the receptor for alpha 1-AT.
- Alpha 1-AT addition fully inhibited cell surface proteolytic activity.
- Alpha 1-AT significantly reduced 3H-thymidine incorporation in lymphocytes stimulated by various agents.
Conclusions:
- Alpha 1-AT binds to a specific protease receptor on lymphocytes.
- This binding modulates lymphocyte activation and proliferation.
- Alpha 1-AT, produced by monocytes, likely acts as a mediator in monocyte-lymphocyte interactions.